GlassScriptPhysician profile
Clayton W Kersting
NPI 1962594234
$16,879.76
in general payments reported to CMS, 2019-2025
19 companies · $14.33 in 2025
The $14.33 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,880 · 2021: $1,445 · 2022: $7,642 · 2023: $1,455 · 2024: $1,445 · 2025: $14.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,881 · Food and Beverage: $32.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,881.25 |
| Food and Beverage | $32.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $11,974.02 | 2021-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $4,298.27 | 2019 | |
| Janssen Pharmaceuticals, INC | $81.01 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.82 | 2019 | |
| Sanofi-Aventis U.S. LLC | $73.41 | 2019 | |
| Abbvie INC. | $50.11 | 2019 | |
| Novo Nordisk INC | $49.05 | 2019 | |
| Lilly USA, LLC | $44.53 | 2019 | |
| Gilead Sciences, INC. | $35.79 | 2019 | |
| Glaxosmithkline, LLC. | $33.85 | 2019 | |
| Amgen INC. | $33.28 | 2019 | |
| Astellas Pharma US INC | $31.16 | 2019 | |
| Novartis Pharmaceuticals Corporation | $21.02 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $16.38 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $14.33 | 2025 | Caplyta |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $13.29 | 2019 | |
| Abbott Laboratories | $11.27 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $11.26 | 2019 | |
| Pfizer INC. | $10.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Kersting listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.